Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Ribaudo

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Infectious Diseases|July 28, 2011
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapyBabafemi Taiwo, Sebastien Gallien, Evgenia Aga, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Margaret A Fischl, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 20, 2011
Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in BotswanaNatasha Parekh, Heather Ribaudo, Sajini Souda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2014
Drug susceptibility and resistance mutations after first-line failure in resource limited settingsCarole L Wallis, Evgenia Aga, Heather Ribaudo, et al.
Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.
Annals of Internal Medicine|November 17, 2005
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsDavid B Clifford, Scott Evans, Yijun Yang, et al.
BMC Pediatrics|July 22, 2016
HIV-exposed children account for more than half of 24-month mortality in BotswanaRebecca Zash, Sajini Souda, Jean Leidner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 21, 2018
Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose MethotrexateJames H Stein, Eunice Yeh, Joanne M Weber, et al.
AIDS (London, England)|September 24, 2011
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionRichard H Haubrich, Sharon A Riddler, Heather Ribaudo, et al.
Open Forum Infectious Diseases|December 20, 2017
Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART InitiationJosh Muhammad, Ellen S Chan, Todd T Brown, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Infectious Diseases|July 28, 2011
Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapyBabafemi Taiwo, Sebastien Gallien, Evgenia Aga, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjectsRobert DiCenzo, Alan Forrest, Margaret A Fischl, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 20, 2011
Risk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in BotswanaNatasha Parekh, Heather Ribaudo, Sajini Souda, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2014
Drug susceptibility and resistance mutations after first-line failure in resource limited settingsCarole L Wallis, Evgenia Aga, Heather Ribaudo, et al.
Antiviral Therapy|September 13, 2006
Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118)Barbara M Gripshover, Heather Ribaudo, Jorge Santana, et al.
Annals of Internal Medicine|November 17, 2005
Impact of efavirenz on neuropsychological performance and symptoms in HIV-infected individualsDavid B Clifford, Scott Evans, Yijun Yang, et al.
BMC Pediatrics|July 22, 2016
HIV-exposed children account for more than half of 24-month mortality in BotswanaRebecca Zash, Sajini Souda, Jean Leidner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 21, 2018
Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose MethotrexateJames H Stein, Eunice Yeh, Joanne M Weber, et al.
AIDS (London, England)|September 24, 2011
Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infectionRichard H Haubrich, Sharon A Riddler, Heather Ribaudo, et al.
Open Forum Infectious Diseases|December 20, 2017
Vitamin D Supplementation Does Not Affect Metabolic Changes Seen With ART InitiationJosh Muhammad, Ellen S Chan, Todd T Brown, et al.
Pageof 5